DoW Arthritis Translational Research Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 1, 2026
- Amount
- Program total $1.6M
- Closes
- Oct 22, 2026 (in 38 days)
Similar opportunities open now
- DoW Arthritis Clinical Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 38 days
- DoW Orthopaedic, Applied Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 65 days
- DoW Orthopaedic, Clinical Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 65 days
- DoW Spinal Cord Injury, Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 59 days
- DoW Toxic Exposures Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 66 days
Classification and identifiers
- Solicitation number
- HT942526ATRPTRA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $1.6M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Translational Research Award (TRA) supports high-impact translational research that will accelerate critical findings into clinically relevant solutions. Research funded under this award mechanism will be hypothesis-driven, high-impact applied research that is relevant to Service Members, Veterans, their Families and the American public. Research addressing any and all types of arthritis is encouraged. Distinctive Features: The FY26 ATRP TRA mechanism is intended to support preclinical or animal research and may not be used for clinical research or clinical trials. Basic research, as defined in Section 3.1.2, is not allowed. A key aspect of this award mechanism is impact. The application should explicitly state how outc...